KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 131 filers reported holding KEZAR LIFE SCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,642 | -55.5% | 34,153 | -8.5% | 0.00% | – |
Q2 2023 | $91,414 | -70.0% | 37,312 | -61.7% | 0.00% | – |
Q1 2023 | $304,546 | -80.9% | 97,299 | -57.0% | 0.00% | -100.0% |
Q4 2022 | $1,592,019 | +651.0% | 226,139 | +818.3% | 0.00% | – |
Q3 2022 | $212,000 | +909.5% | 24,625 | +886.2% | 0.00% | – |
Q2 2022 | $21,000 | -99.2% | 2,497 | -98.5% | 0.00% | -100.0% |
Q1 2022 | $2,708,000 | +65.0% | 162,913 | +66.0% | 0.00% | – |
Q4 2021 | $1,641,000 | +882.6% | 98,122 | +406.0% | 0.00% | – |
Q3 2021 | $167,000 | -53.7% | 19,390 | -70.9% | 0.00% | – |
Q2 2021 | $361,000 | +1103.3% | 66,602 | +1229.6% | 0.00% | – |
Q1 2021 | $30,000 | -3.2% | 5,009 | -16.3% | 0.00% | – |
Q4 2020 | $31,000 | +72.2% | 5,984 | +62.0% | 0.00% | – |
Q3 2020 | $18,000 | -56.1% | 3,693 | -52.9% | 0.00% | – |
Q2 2020 | $41,000 | -48.1% | 7,842 | -56.5% | 0.00% | – |
Q1 2020 | $79,000 | +2.6% | 18,046 | -6.3% | 0.00% | – |
Q4 2019 | $77,000 | +32.8% | 19,252 | +9.8% | 0.00% | – |
Q3 2019 | $58,000 | +132.0% | 17,526 | +442.3% | 0.00% | – |
Q2 2019 | $25,000 | -44.4% | 3,232 | +69.9% | 0.00% | – |
Q4 2018 | $45,000 | +12.5% | 1,902 | +2.8% | 0.00% | – |
Q3 2018 | $40,000 | – | 1,850 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |